Safety and Efficacy of PRO 542 in the Treatment of HIV-Infected Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00055185
Recruitment Status : Completed
First Posted : February 21, 2003
Last Update Posted : October 3, 2008
Information provided by:
Progenics Pharmaceuticals, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Actual Study Completion Date : June 2005